LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa
Based on the structure of AAP, a novel anti-thrombotic peptide from snake venom which we discovered in our previous study, more than 60 compounds were designed and synthesized. One of these termed as LX0702 exhibited stronger anti-platelet aggregation activity than AAP. This study aims to investigat...
Saved in:
Main Authors: | Yi Kong (Author), Ying Wang (Author), Wei Yang (Author), Zhouling Xie (Author), Zhiyu Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
by: Chen H, et al.
Published: (2018) -
Snake Venom Cathelicidins as Natural Antimicrobial Peptides
by: Elizângela de Barros, et al.
Published: (2019) -
Engineered nanoparticles bind elapid snake venom toxins and inhibit venom-induced dermonecrosis.
by: Jeffrey O'Brien, et al.
Published: (2018) -
From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides
by: Wei Fong Ang, et al.
Published: (2022) -
Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin
by: Hui Wang, et al.
Published: (2023)